Safeway’s Dominick’s division president resigns
PLEASANTON, Calif. — Safeway on Thursday announced the resignation of Don Keprta, president of its Chicago-area Dominick’s Finer Foods division.
"Don has contributed significantly to the Dominick’s stores. His commitment and innovation helped the stores evolve to best serve the Chicagoland customers,” stated Steve Burd, Safeway chairman, president and CEO. “We are fortunate that he has produced a team that is prepared to continue to build on our current momentum.”
As president of Dominick’s since 2005, Keprta is credited with opening a number of new stores, expanding the lifestyle store remodels and improving store operating standards and metrics. As a corporate leader, Keprta also was very active in the community, sitting on a number of committees and boards for charitable organizations in the Chicago area. He also served on the executive committee and retail board for the Illinois Retail Merchants Associations and as a board member for the Chicagoland Chamber of Commerce.
Brian Baer, Dominick’s CFO and VP finance, will assume the role of acting president of Dominick’s. Baer joined Safeway in 2001 as VP finance for the Phoenix division. In 2004 he became group VP finance, planning and analysis at the company’s corporate office. Baer came to Dominick’s in his current role in 2008.
Prior to joining Safeway, Baer spent more than 12 years with the Marriott Corp. serving in various financial management positions in operations, corporate finance and real estate development.
WHO increases number of approved seasonal flu vaccines
GENEVA — The World Health Organization on Thursday announced 11 new manufacturers of the seasonal flu vaccine, a development that is expected to double the number of influenza doses to 1.7 billion worldwide by 2015, according to published reports.
In all, there now are 37 approved vaccine manufacturers that potentially could triple their annual production to make as much as 5.4 billion pandemic vaccinations in the event of another H1N1-type outbreak.
Over the course of the H1N1 outbreak, the WHO had come under criticism for not having enough pandemic vaccine production capacity approved.
GlaxoSmithKline and Sanofi are among the major producers of influenza vaccines.
Clorox receives acquisition proposal from Icahn Enterprises
OAKLAND, Calif. — Clorox on Friday confirmed it has received an unsolicited conditional proposal from Icahn Enterprises to acquire the company for $76.50 per share, subject to due diligence, financing and other conditions. Clorox said its board of directors, in consultation with its financial and legal advisers, will review the proposal in due course.
Goldman, Sachs & Co. and J.P. Morgan Securities are serving as financial advisers, and Wachtell, Lipton, Rosen & Katz is legal adviser.